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Understanding molecular mechanisms of aging is crucial in efforts to reverse it. In a recent issue of Nature,
Florian et al. (2013) report that increasing levels of noncanonical Wnt signaling accompany hematopoietic
stem cell (HSC) aging, which can be modulated to functionally rejuvenate HSCs.In many regions of our planet, the human
population is aging, providing an impor-
tant societal incentive for biomedical
researchers to identify the molecular
mechanisms that contribute to the aging
process and to explore ways to halt or
reverse it. Organismal aging is associated
with decreased organ function and regen-
eration, resulting in increased morbidity
and mortality. In the hematopoietic
system, aging is associated with the
development of immunodeficiencies,
anemias, and an elevated risk of malig-
nancies. A growing body of data suggests
that these phenotypes result from
changes in the pool of HSCs that are
responsible for lifelong production of all
blood and immune cells. The possibility
to rejuvenate stem cells holds promise
to reset the aging clock. Recent studies
in heart, muscle, skin, and blood show
that changes in signaling pathways (Wnt,
Notch, TGF-b, NFkB, and mTOR) may
underlie (stem) cell aging, and, excitingly,
modulation of these pathways may
restore tissues to a more youthful state
(Loffredo et al., 2013; Rando and Chang,
2012; Signer and Morrison, 2013). Now,
a report of Florian et al. suggests that
activation of noncanonical Wnt signaling
in HSCs is responsible for reversible
age-related deterioration in the hemato-
poietic system (Florian et al., 2013).
The hallmarks of aging of HSCs include:
(1) increased HSC pool size; (2) skewing
of hematopoiesis toward the myeloid line-
age and an increase of myeloid-dominant
HSCs in the HSC pool; and (3) decreased
repopulation potential per HSC (Figure 1)
(Dykstra et al., 2011; Geiger et al., 2013).
Moreover, HSCs from old mice demon-
strate a reduced ability to home and
engraft bone marrow niches, and they642 Cell Stem Cell 13, December 5, 2013 ª2show increased mobilization in response
to cytokines (Dykstra et al., 2011; Geiger
et al., 2013). Although the phenotype of
aged HSCs has now been well described,
the molecular mechanisms that con-
tribute to stem cell aging are not well
understood. HSC aging has been associ-
atedwith an upregulation ofmyeloid and a
concomitant downregulation of lymphoid
genes, increased production of reactive
oxygen species, elevated levels of DNA
damage, and an activation of proinflam-
matory molecules (Geiger et al., 2013).
Recently, loss of cell polarity, modulated
by the small Rho GTPase Cdc42, in old
HSCs has been described as a novel
aging mechanism (Florian et al., 2012). In
a recent issue of Nature, the same group
now proposes that the underlying cause
of HSC aging is a shift from canonical
to noncanonical Wnt signaling (Florian
et al., 2013).
The Wnt pathway is an evolutionarily
conserved signaling cascade that regu-
lates a wide variety of processes,
including embryonic organogenesis and
stem cell proliferation in adults. The Wnt
signaling network is highly complex:
19 secreted Wnt proteins have been
described in mammals, all of which
together can bind to more than 15 recep-
tors and coreceptors (Niehrs, 2012). Wnt
can act in both an autocrine and paracrine
fashion. The best-studied (canonical) Wnt
signaling pathway is b-catenin dependent
and results in activation of target genes of
the transcription factor family Tcf/Lef. Wnt
pathways that do not rely on b-catenin are
cumulatively referred to as noncanonical,
and they have been shown to be impor-
tant for establishment of cell polarity and
cell migration. While binding of Wnt
protein to its receptor and coreceptor013 Elsevier Inc.determines which downstream pathway
is induced, some Wnt ligands (Wnt1,
Wnt3A, and Wnt8) have been associated
with predominantly canonical signaling
while others (Wnt5A and Wnt11) appear
involved in noncanonical signaling
(Niehrs, 2012). Noncanonical Wnt activa-
tion inhibits the canonical pathway, at
least partially as a result of competition
for receptor binding. In the hematopoietic
system, the role of Wnt signaling has thus
far been controversial (Luis et al.,
2012). For instance, studies modulating
canonical Wnt activity report pronounced
augmentation but also total exhaustion of
HSC function in response to b-catenin
overexpression (Luis et al., 2012). It has
been proposed that levels of Wnt
signaling are tightly regulated and dose-
dependently affect HSCs (Luis et al.,
2012).
The current study of Florian et al.
describes a new role for the Wnt cascade
in HSCs and suggests that the balance
between canonical and noncanonical
Wnt ligand expression, and therefore
Wnt signaling, underlies HSC aging (Flo-
rian et al., 2013). The authors show that
the levels of Wnt5a are significantly
elevated in aged long-term HSCs (LT-
HSCs), while expression of canonical
Wnt ligands remains unaltered during
aging (Figure 1B).
Previously, Cdc42, a downstream
effector of noncanonical Wnt signaling,
had been associated with HSC aging by
this same group (Florian et al., 2012). In
aged HSCs, elevated levels of Cdc42 are
associated with cell depolarization, in
contrast to predominantly polarized distri-
bution of tubulin and Cdc42 in young
HSCs (Florian et al., 2012). Now,
the authors report that the number of
Figure 1. Changes in Wnt Signaling Accompany Aging in the HSC Pool
(A) Heterogeneity of the developmental potential of HSCs. Based on their ability to produce differentiated
output, HSCs at the single-cell level can be classified as balanced, lymphoid-dominant, or myeloid-
dominant.
(B) Changes in the HSC pool upon aging. During aging, the number of phenotypically defined HSCs
increases dramatically, whereas both the frequency of functional HSCs within the putative pool and the
repopulation capacity per HSC decreases. Production of mature cells becomes skewed toward the
myeloid lineage. The levels of canonical Wnt proteins remain constant over the life span, while the levels
of noncanonical Wnt proteins increase, leading to inhibition of canonical signaling.
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Previewspolarized HSCs is negatively correlated
with Wnt5a levels (Florian et al., 2013).
Increasing or decreasing Wnt5a levels
leads to induction or reversal of age-
related HSC phenotypes, respectively.
Exposure of HSCs to Wnt5a induced
lymphoid to myeloid skewing of donor
cells in blood after transplantation,
while conversely, Wnt5a downregulation
increased lymphoid chimerism from
aged HSCs. Moreover, the age-related
increase of the fraction of phenotypically
defined LT-HSCs was attenuated in aged
Wnt5a+/ mice, and a similar effect was
observed in recipients of aged Wnt5a
shRNA-transduced bone marrow cells.
While these data provide exciting sup-
port for the notion that age-related HSC
changes can be attenuated by alterationof signaling, several important questions
remain. It has now become evident that
individual HSCs are highly heterogeneous
in their turnover rate and their develop-
mental and repopulating potential (Fig-
ure 1). The ratio between these distinct
types of HSCs shifts with age and is re-
flected in changes of cellular constituents
in blood. The experiments by Florian
et al. were performed using populations
of cells, and the effect of Wnt5a on
different individual HSCs cannot be
distinguished. Therefore, an alternative
explanation of the observed reversal of
myeloid/lymphoid skewing upon Wnt5a
downregulation is preferential survival of
balanced/lymphoid-dominant cells upon
treatment. Moreover, one of the key
features of HSC aging is a stronglyCell Stem Cell 13,decreased self-renewal and repopulation
capacity in phenotypically defined indi-
vidual HSCs. It remains unclear whether
inhibition of Wnt5a in aged HSCs results
in improved reconstitution ability in pri-
mary and secondary recipients, and
whether the frequency of functional
HSCs is increased. It is striking that the
aging HSC phenotype could be induced
by only a 16 hr incubation period with
Wnt5a ligand. As biological aging is pro-
posed to be at least partly mediated by
changes in the epigenome (Rando and
Chang, 2012), it is remarkable that an
exposure period shorter than one cell
division can have such a profound effect.
The experiments by Florian et al. (2013)
provide a novel perspective on hemato-
poietic stem cell aging. The studies
suggest that potentially reversible cell-
intrinsic mechanisms are involved in this
process. For a clear understanding of
such rejuvenation process, it will be
essential to uncover additional mecha-
nisms and the kinetics of changes of the
epigenetic landscape that coincide with
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